First Pacific Financial’s Royalty Pharma RPRX Stock Holding History

First Pacific Financial’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$10.7K	Sell	183 -35	-16%	-$2.06K	﹤0.01%	413
2026 Q2	$12.2K	Buy	218 +87	+66%	+$4.53K	﹤0.01%	382
2026 Q1	$6.29K	Buy	131 +40	+44%	+$1.75K	﹤0.01%	433
2025 Q4	$3.52K	Buy	+91	New	+$3.47K	﹤0.01%	424
2024 Q2	–	Sell	-87	Closed	-$2.64K	–	460
2024 Q1	$2.64K	Buy	87 +25	+40%	+$737	﹤0.01%	340
2023 Q4	$1.74K	Buy	+62	New	+$1.7K	﹤0.01%	322

Other funds holding RPRX

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

TPM

Triasima Portfolio Management Montreal, Quebec, Canada $758M AUM 48.16% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

First Pacific Financial's RPRX Position: Q3 2026 in Review

First Pacific Financial reduced its Royalty Pharma (RPRX) stake by 16% in Q3 2026, selling an estimated $2.06K and leaving 183 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #413.

First Pacific Financial first reported a position in RPRX in Q4 2023 and has held it in 6 quarters since. The position peaked at $12.2K in Q2 2026. 67 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

First Pacific Financial held 183 shares of Royalty Pharma worth $10.7K as of Q3 2026.
First Pacific Financial sold 35 Royalty Pharma shares in Q3 2026, an estimated $2.06K.
Royalty Pharma made up ﹤0.01% of First Pacific Financial's portfolio in Q3 2026, its #413 holding.
First Pacific Financial first reported a position in Royalty Pharma in Q4 2023 and has held it in 6 quarters since.
First Pacific Financial's Royalty Pharma position peaked at $12.2K in Q2 2026.
67 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on First Pacific Financial's 13F filing for Q3 2026, filed 14 Oct 2026.